These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38326745)

  • 1. Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients.
    Li C; Liu H; Duan Z
    BMC Immunol; 2024 Feb; 25(1):12. PubMed ID: 38326745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the TIGIT-CD226-CD112-CD155 Immune Checkpoint Network during a Healthy Pregnancy.
    Meggyes M; Nagy DU; Feik T; Boros A; Polgar B; Szereday L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142692
    [No Abstract]   [Full Text] [Related]  

  • 3. Examination of the TIGIT, CD226, CD112, and CD155 Immune Checkpoint Molecules in Peripheral Blood Mononuclear Cells in Women Diagnosed with Early-Onset Preeclampsia.
    Szereday L; Nagy DU; Csiszar B; Kevey D; Feik T; Meggyes M
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIGIT and CD155 as Immune-Modulator Receptor and Ligand on CD4
    Kamrani A; Soltani-Zangbar MS; Shiri S; Yousefzadeh Y; Pourakbari R; Aghebati-Maleki L; Mehdizadeh A; Danaii S; Jadidi-Niaragh F; Yousefi B; Kafil HS; Hojjat-Farsangi M; Motavalli R; Zolfaghari M; Haji-Fatahaliha M; Mahmoodpoor A; Ahmadian Heris J; Emdadi A; Yousefi M
    Immunol Invest; 2022 May; 51(4):1023-1038. PubMed ID: 33855917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis.
    Deng C; Li W; Fei Y; Wang L; Chen Y; Zeng X; Zhang F; Li Y
    Front Immunol; 2020; 11():1619. PubMed ID: 32793241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Profiling of CD8
    Szereday L; Nagy DU; Vastag F; Mezosi L; Meggyes M
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
    Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
    J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of mucosal-associated invariant T (MAIT) cells expressing immune checkpoint receptors (TIGIT and CD226) in early-onset preeclampsia.
    Meggyes M; Nagy DU; Szigeti B; Csiszar B; Sandor B; Tamas P; Szereday L
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():373-381. PubMed ID: 32682212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD226 opposes TIGIT to disrupt Tregs in melanoma.
    Fourcade J; Sun Z; Chauvin JM; Ka M; Davar D; Pagliano O; Wang H; Saada S; Menna C; Amin R; Sander C; Kirkwood JM; Korman AJ; Zarour HM
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD226 and TIGIT Cooperate in the Differentiation and Maturation of Human Tfh Cells.
    Yasutomi M; Christiaansen AF; Imai N; Martin-Orozco N; Forst CV; Chen G; Ueno H
    Front Immunol; 2022; 13():840457. PubMed ID: 35273617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8
    Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
    Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD155/TIGIT, a novel immune checkpoint in human cancers (Review).
    Liu L; You X; Han S; Sun Y; Zhang J; Zhang Y
    Oncol Rep; 2021 Mar; 45(3):835-845. PubMed ID: 33469677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus.
    Hoseini-Aghdam M; Sheikh V; Eftekharian MM; Rezaeepoor M; Behzad M
    Immunol Lett; 2020 Sep; 225():1-8. PubMed ID: 32540486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8
    Banta KL; Xu X; Chitre AS; Au-Yeung A; Takahashi C; O'Gorman WE; Wu TD; Mittman S; Cubas R; Comps-Agrar L; Fulzele A; Bennett EJ; Grogan JL; Hui E; Chiang EY; Mellman I
    Immunity; 2022 Mar; 55(3):512-526.e9. PubMed ID: 35263569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis.
    Li W; Deng C; Yang H; Lu X; Li S; Liu X; Chen F; Chen L; Shu X; Zhang L; Liu Q; Wang G; Peng Q
    Arthritis Res Ther; 2021 Jan; 23(1):15. PubMed ID: 33413573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of CD226-TIGIT
    Long Y; Wang C; Xia C; Li X; Fan C; Zhao X; Liu C
    Immunol Lett; 2020 Feb; 218():30-39. PubMed ID: 31883787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD4
    Šunina M; Alnek K; Kisand K; Uibo R
    Scand J Immunol; 2021 Sep; 94(3):e13089. PubMed ID: 35971920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in CD226 expression on CD4
    Li C; Zhou J; Shao J; Yuan L; Cheng Q; Wang L; Duan Z
    Biosci Trends; 2023 May; 17(2):168-171. PubMed ID: 37081668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.
    Chauvin JM; Ka M; Pagliano O; Menna C; Ding Q; DeBlasio R; Sanders C; Hou J; Li XY; Ferrone S; Davar D; Kirkwood JM; Johnston RJ; Korman AJ; Smyth MJ; Zarour HM
    Clin Cancer Res; 2020 Oct; 26(20):5520-5533. PubMed ID: 32591463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma.
    Wu L; Mao L; Liu JF; Chen L; Yu GT; Yang LL; Wu H; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Cancer Immunol Res; 2019 Oct; 7(10):1700-1713. PubMed ID: 31387897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.